Civitas Solutions Inc (NYSE:CIVI) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: October 16, 2016
Having a price of $18.01, Civitas Solutions Inc (NYSE:CIVI) traded -1.24% lower on the day. The last stock price is down -6.75% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. CIVI has recorded a 50-day moving average of $18.13 and a 200-day moving average of $19.63. 33,655 shares of CIVI traded hands, down from an average trading volume of 86,818
Zacks Investment Research has upgraded Civitas Solutions Inc (NYSE:CIVI) to Hold in a statement released on 10/11/2016.
On 9/27/2016, UBS Securities released a statement on Civitas Solutions Inc (NYSE:CIVI) dropped the target price from $28.00 to $24.00 that suggested an upside of 0.32%.
With a total market value of $0, Civitas Solutions Inc has price-earnings ratio of 62.89 with a one year low of $15.19 and a one year high of $30.23 .
Brief Synopsis About Civitas Solutions Inc (NYSE:CIVI)
Civitas Solutions, Inc. is a provider of home and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. The Company's clinicians and caregivers develop customized service plans, delivered in non-institutional settings, designed to address a range of often life-long conditions. The Company operates through two segments: Human Services and Post-Acute Specialty Rehabilitation Services (SRS). The Company's Human Services segment provides home and community-based human services to individuals with intellectual and/or developmental disabilities, youth with emotional, behavioral and/or medically complex challenges, or at-risk youth and elders. The Company's SRS segment delivers healthcare and community-based health and human services to individuals who have suffered acquired brain injury, spinal injuries and other catastrophic injuries and illnesses.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.